As potential biomarkers of pancreatic cancer, TRPM7 and TRPM8 channels can be exploited to characterize the molecular phenotype of tumors, to facilitate early detection of primary and metastatic tumors, to monitor and predict treatment responses, to determine patient prognosis, and to aid targeted delivery of cancer-specific therapeutics. This evidence concerns the gene TRPM8 and pancreatic neoplasm.